Global Impetigo Treatment Market 2019-2023 | Increase in Pediatric Population to Boost Demand | Technavio
LONDON--(BUSINESS WIRE)--Jan 4, 2019-- analysts forecast the global impetigo market to grow at a CAGR of 7% during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190104005284/en/
Technavio analysts forecast the global impetigo market to grow at a CAGR of 7% by 2023. (Graphic: Business Wire)
Development of therapies for the novel drug is one of the major trends being witnessed in the . There has been an increase in the R&D of therapies for impetigo treatment over the past years. Global Health, an organization developing a novel drug for neglected diseases, has developed moxidectin for the treatment of scabies which is associated with impetigo treatment. Currently, manufacturers such as Teva pharmaceutical industries and GlaxoSmithKline are focusing on the product improvement and development of therapies for a novel drug that can help in impetigo treatment at a faster rate.
According to Technavio analysts, one of the key factors contributing to the growth of the global impetigo treatment market is the increase in the pediatric population:
Global impetigo treatment market: Increase in the pediatric population
The impetigo skin disease occurs mostly in the pediatric population, affecting mostly 2-5-year-old children. It is the most common bacterial infection among children and is often called school sores since it is common among school children. Since the pediatric population is the high-risk group for this disease, the increase in the pediatric population is a driver for the market.
According to a senior analyst at Technavio, “Impetigo mainly occurs in children living in a warm and humid climate and presently around 40% of the world’s population is living in tropical areas. Thus, the prevalence of impetigo is highest in the Pacific due to the prevalence of tropical climate.”
Global impetigo treatment market: Segmentation analysis
The global impetigo treatment market research report provides market segmentation by product (topical and oral) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The Americas held the largest share of the market in 2018, accounting for more than 39% share. It was followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the low cost of impetigo treatment and initiatives to increase awareness of skin diseases.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20190104005284/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 01/04/2019 08:48 AM/DISC: 01/04/2019 08:47 AM